FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Ginn Scott G 		2. Issuer Name and Ticker or Trading Symbol

AMEDISYS INC [ AMED ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
See Remarks
(Last)          (First)          (Middle)

5959 S. SHERWOOD FOREST BLVD. 		3. Date of Earliest Transaction (MM/DD/YYYY)

3/3/2016
(Street)

BATON ROUGE, LA 70816
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

3/28/2016 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit     (2) 3/3/2016     M         1875   (1)     (2)   (2) Common Stock   1875   $0.00   5625   D    
Restricted Stock Unit     (3) 3/24/2016     M         5247   (1)     (3)   (3) Common Stock   5247   $0.00   0   D    

Explanation of Responses:
( 1)  This amendment is being filed to report the deemed disposition of performance-based Restricted Stock Units ("RSUs") in connection with the acquisition of the underlying common stock upon the vesting of the RSUs previously reported on a Form 4 filed on March 28, 2016.
( 2)  Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs are subject to performance-based vesting and will vest, if at all, based (i) on the certification by the Compensation Committee of the Issuer's Board of Directors of the achievement of identified performance goals for fiscal years 2015 through 2018, respectively, and (ii) additional time-based vesting conditions (1/3 at the end of the applicable performance period; 1/3 12 months thereafter and 1/3 24 months thereafter), assuming the Reporting Person remains continuously employed by the Issuer on each date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs. The number of performance-based vesting RSUs listed in Table II, Column 9 represents the maximum number of shares of common stock the Reporting Person would receive based on the satisfaction of all of the remaining pre-determined performance conditions.
( 3)  Each RSU represented a contingent right to receive one share of the Issuer's common stock with vesting conditions based on the Issuer's compound total shareholder return (TSR) over defined measurement periods. The number of shares of Issuer common stock earned upon the vesting of the RSUs was 8,396, which amount represents 160% of the number of RSUs reported in Column 5 of Table II of the Reporting Person's Form 4 filed on April 3, 2013.

Remarks:
Principal Accounting Officer, SVP - Accounting and Controller

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Ginn Scott G
5959 S. SHERWOOD FOREST BLVD.
BATON ROUGE, LA 70816

See Remarks

Signatures
/s/ Jennifer R. Guckert, pursuant to a power of attorney 5/13/2016
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Amedisys Charts.
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Amedisys Charts.